Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30

$8.09−0.04 (-0.49%)

Close on Nov 13, 2026Market cap $466.68MP/E –Yield –

Kamada EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $0.35, up 40.0% from the year before. The highest annual figure on record is $0.55 in fiscal 2018.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$0.35	+40.0%
FY2024	Dec 31, 2024	$0.25	+66.7%
FY2023	Dec 31, 2023	$0.15	–
FY2022	Dec 31, 2022	-$0.05	–
FY2021	Dec 31, 2021	-$0.05	-113.2%
FY2020	Dec 31, 2020	$0.38	-30.9%
FY2019	Dec 31, 2019	$0.55	0.0%
FY2018	Dec 31, 2018	$0.55	+205.6%
FY2017	Dec 31, 2017	$0.18	–
FY2016	Dec 31, 2016	-$0.18	–
FY2015	Dec 31, 2015	-$0.31	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$0.16	+128.6%
Q1 FY2026	Mar 31, 2026	$0.07	0.0%
Q3 FY2025	Sep 30, 2025	$0.09	+12.5%
Q2 FY2025	Jun 30, 2025	$0.13	+225.0%
Q1 FY2025	Mar 31, 2025	$0.07	+16.7%
Q3 FY2024	Sep 30, 2024	$0.07	+75.0%
Q2 FY2024	Jun 30, 2024	$0.08	–
Q1 FY2024	Mar 31, 2024	$0.04	+300.0%
Q3 FY2023	Sep 30, 2023	$0.06	–
Q2 FY2023	Jun 30, 2023	$0.04	–
Q1 FY2023	Mar 31, 2023	-$0.04	–
Q3 FY2022	Sep 30, 2022	$0.01	-50.0%
Q2 FY2022	Jun 30, 2022	-$0.09	-160.0%
Q1 FY2022	Mar 31, 2022	-$0.04	–
Q3 FY2021	Sep 30, 2021	-$0.02	–
Q2 FY2021	Jun 30, 2021	$0.02	–
Q3 FY2020	Sep 30, 2020	$0.15	–